loading

Organogenesis Holdings Inc Borsa (ORGO) Ultime notizie

pulisher
03:22 AM

Organogenesis Holdings Inc. (NASDAQ:ORGO) Stake Boosted by Barclays PLC - Defense World

03:22 AM
pulisher
Dec 30, 2024

Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by State Street Corp - Defense World

Dec 30, 2024
pulisher
Dec 29, 2024

Organogenesis Holdings Inc. (NASDAQ:ORGO) Short Interest Up 29.1% in December - MarketBeat

Dec 29, 2024
pulisher
Dec 20, 2024

Organogenesis signs Smithfield lease with subsidies in hand - The Business Journals

Dec 20, 2024
pulisher
Dec 19, 2024

Fmr LLC Buys 44,199 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Dec 19, 2024
pulisher
Dec 16, 2024

Gary S. Gillheeney Sells 5,585 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) Stock - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Organogenesis Holdings Inc. (NASDAQ:ORGO) CEO Gary S. Gillheeney Sells 55,615 Shares - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Organogenesis CEO Gary Gillheeney sells shares worth $206,358 - Investing.com

Dec 16, 2024
pulisher
Dec 16, 2024

US Penny Stocks To Consider In December 2024 - Simply Wall St

Dec 16, 2024
pulisher
Dec 16, 2024

Charles Schwab Investment Management Inc. Grows Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Dec 16, 2024
pulisher
Dec 16, 2024

Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by Verition Fund Management LLC - Defense World

Dec 16, 2024
pulisher
Dec 16, 2024

Organogenesis Holdings Inc. (NASDAQ:ORGO) Position Cut by BNP Paribas Financial Markets - Defense World

Dec 16, 2024
pulisher
Dec 12, 2024

Organogenesis CEO Gary Gillheeney sells shares worth $940,066 - Investing.com

Dec 12, 2024
pulisher
Dec 12, 2024

Organogenesis CEO Gary Gillheeney sells shares worth $940,066 By Investing.com - Investing.com UK

Dec 12, 2024
pulisher
Dec 11, 2024

Wound Care Market 2024By Industry Outlook, Future Trends, - openPR

Dec 11, 2024
pulisher
Dec 10, 2024

Organogenesis CEO Gillheeney sells shares worth $211,721 - Investing.com India

Dec 10, 2024
pulisher
Dec 10, 2024

Organogenesis CEO Gillheeney sells shares worth $211,721 By Investing.com - Investing.com Nigeria

Dec 10, 2024
pulisher
Dec 10, 2024

Jacobs Levy Equity Management Inc. Lowers Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat

Dec 10, 2024
pulisher
Dec 03, 2024

Organogenesis Holdings Inc (NASDAQ: ORGO) -0.26% Decline Turns Investors Away - Stocks Register

Dec 03, 2024
pulisher
Dec 02, 2024

Organogenesis Holdings Inc. announces an Equity Buyback for 500,000 shares, for $2.03 million. - Marketscreener.com

Dec 02, 2024
pulisher
Dec 02, 2024

Organogenesis announces stock repurchase at trailing average price By Investing.com - Investing.com Australia

Dec 02, 2024
pulisher
Dec 02, 2024

Organogenesis announces stock repurchase at trailing average price - Investing.com

Dec 02, 2024
pulisher
Nov 27, 2024

Advantage Alpha Capital Partners LP Trims Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat

Nov 27, 2024
pulisher
Nov 25, 2024

News | Massachusetts-based regenerative tissue medical firm expands in Rhode Island - CoStar Group

Nov 25, 2024
pulisher
Nov 25, 2024

News | Massachusetts-based regenerative medical firm expands in Rhode Island - CoStar Group

Nov 25, 2024
pulisher
Nov 23, 2024

Organogenesis Expands Manufacturing Capacity to Support Future Growth - The Manila Times

Nov 23, 2024
pulisher
Nov 22, 2024

Organogenesis Holdings Inc. Expands Manufacturing Capacity to Support Future Growth - Marketscreener.com

Nov 22, 2024
pulisher
Nov 22, 2024

Organogenesis Secures 122,000 Sq Ft Biomanufacturing Facility in Major Expansion | ORGO Stock News - StockTitan

Nov 22, 2024
pulisher
Nov 21, 2024

Organogenesis Holdings Inc. Appoints Garrett Lustig to the Board - Marketscreener.com

Nov 21, 2024
pulisher
Nov 18, 2024

Analysts Set Expectations for Organogenesis FY2024 Earnings - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

Organogenesis Holdings’ $130 Million Private Placement Offering of Series A Convertible Preferred Stock - Global Legal Chronicle

Nov 18, 2024
pulisher
Nov 18, 2024

FY2024 EPS Estimates for Organogenesis Boosted by Analyst - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

Organogenesis (NASDAQ:ORGO) Releases Quarterly Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Organogenesis Commends Final LCDs - The Manila Times

Nov 15, 2024
pulisher
Nov 15, 2024

Organogenesis Secures Medicare Coverage for Wound Care Products in Key CMS Decision | ORGO Stock News - StockTitan

Nov 15, 2024
pulisher
Nov 14, 2024

Organogenesis (NASDAQ:ORGO) Shares Gap DownWhat's Next? - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Earnings call: Organogenesis tops Q3 revenue forecast with $115.2M - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Organogenesis Holdings Secures $130M Investment for Growth - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Organogenesis secures $130 million investment By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 13, 2024

Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Organogenesis: Q3 Earnings Snapshot - The Washington Post

Nov 13, 2024
pulisher
Nov 12, 2024

Organogenesis Reports Robust Third Quarter Growth - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Organogenesis (ORGO) Q3 2024 Earnings Call Transcript - The Motley Fool

Nov 12, 2024
pulisher
Nov 12, 2024

Organogenesis (ORGO) Tops Q3 Earnings and Revenue Estimates - Yahoo Canada Finance

Nov 12, 2024
pulisher
Nov 12, 2024

Organogenesis Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock - The Manila Times

Nov 12, 2024
$11.89
price down icon 0.90%
$92.94
price up icon 1.90%
$81.80
price down icon 2.00%
drug_manufacturers_specialty_generic RDY
$15.46
price up icon 0.10%
$136.66
price down icon 1.00%
$11.95
price down icon 2.73%
Capitalizzazione:     |  Volume (24 ore):